Approval · Notice of Compliance 4059 · 1997
ASMAVENT: Notice of Compliance 4059
Issued June 11, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4059
- Date
- June 11, 1997
- Company
- Technilab Pharma Inc.Mirabel, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Bronchodilator
- Canadian reference product
- VENTOLIN NEBULES P.F. (Glaxo Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASMAVENT | 02231430 | Cancelled Post Market |
Medicinal ingredients
- SALBUTAMOL 2.5 MG per 2.5ML